Clinical trial
HE4 is a Beneficial Biomarker in Endometrial Cancer
NCT03459976 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- HE4 is a Beneficial Biomarker in Endometrial Cancer
- Lead sponsor
- Ain Shams University
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- December 1, 2017
- Completion date
- April 1, 2019
- Enrollment
- 87 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
endometrial cancer